Vor Bio to Participate in Upcoming Investor Conferences
03 Novembro 2023 - 9:00AM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in the following
upcoming investor conferences:
Stifel 2023 Healthcare ConferenceFireside Chat:
Tuesday, November 14, 2023 at 3:35 pm ET Location: Lotte New York
Palace Hotel, New York, NY
A live webcast and archived replay of the fireside chat will be
available on the investors section of www.vorbio.com.
6th Annual Evercore ISI HealthCONx Conference
Fireside Chat: Wednesday, November 29, 2023 at
3:00 pm ETLocation: Kimpton EPIC Hotel, Miami, FL
Piper Sandler 35th Annual Healthcare
ConferenceFireside Chat: Thursday, November 30, 2023 at
2:00 pm ET Location: Lotte New York Palace Hotel, New York, NY
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Vor Biopharma (NASDAQ:VOR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024